Sayuri Konishi, Dai Manaka, Yuji Yoshida, Shu Yamamoto, Kota Yamashita, Ryo Kudo et al. Minimum 7‐Year Follow‐Up of a Prospective Phase II Trial of Preoperative S‐1 Plus Oxaliplatin Chemotherapy for Clinical Stage III Gastric Cancer. // Asia-Pacific Journal of Clinical Oncology. – 2026. – DOI: 10.1111/ajco.70214. – URL: https://onlinelibrary.wiley.com/doi/10.1111/ajco.70214?af=R
Sayuri Konishi, Dai Manaka, Yuji Yoshida, Shu Yamamoto, Kota Yamashita, Ryo Kudo, Michina Morioka, Ryo Takahashi, Daisuke Yamaguchi, & Shigehiko Fujii (2026). Minimum 7‐Year Follow‐Up of a Prospective Phase II Trial of Preoperative S‐1 Plus Oxaliplatin Chemotherapy for Clinical Stage III Gastric Cancer. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.70214
Sayuri Konishi, et al. “Minimum 7‐Year Follow‐Up of a Prospective Phase II Trial of Preoperative S‐1 Plus Oxaliplatin Chemotherapy for Clinical Stage III Gastric Cancer.” Asia-Pacific Journal of Clinical Oncology, 2026. doi:10.1111/ajco.70214.
@article{Konishi2026,
title = {Minimum 7‐Year Follow‐Up of a Prospective Phase II Trial of Preoperative S‐1 Plus Oxaliplatin Chemotherapy for Clinical Stage III Gastric Cancer},
author = {Konishi, Sayuri and Manaka, Dai and Yoshida, Yuji and Yamamoto, Shu and Yamashita, Kota and Kudo, Ryo and Morioka, Michina and Takahashi, Ryo and Yamaguchi, Daisuke and Fujii, Shigehiko},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
doi = {10.1111/ajco.70214},
url = {https://onlinelibrary.wiley.com/doi/10.1111/ajco.70214?af=R}
}